Purchases and Sales Made in Q4 2023 in Vincerx Pharma, Inc. (VINC)
This table provides information about the institutional ownership of Vincerx Pharma, Inc. (VINC) during Q4 2023. The information is specifically focused on institutions that hold shares of Vincerx Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.08M+ 28737.9% |
$669K - $1.27M
|
1.08M
$206K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
43.1K+ 32.45% |
$26.7K - $50.9K
|
176K
$33.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
28.5K+ 16.9% |
$17.7K - $33.7K
|
197K
$37.5K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
16K+ 914.57% |
$9.92K - $18.9K
|
17.8K
$3.37K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
7+ 5.56% |
$4.34 - $8.26
|
133
$25.3
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-1.83K- 25.48% |
$1.13K - $2.16K
|
5.35K
$1.02K
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-2.53K- 99.1% |
$1.57K - $2.99K
|
23
$4.37
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-2.79K- 48.59% |
$1.73K - $3.29K
|
2.95K
$560
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.07K- 28.47% |
$4.38K - $8.34K
|
17.8K
$3.37K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-24.6K- 41.62% |
$15.2K - $29K
|
34.5K
$6.55K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-353K- 17.12% |
$219K - $417K
|
1.71M
$325K
|